Wenkai Ni

1.4k total citations
42 papers, 1.1k citations indexed

About

Wenkai Ni is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Wenkai Ni has authored 42 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 14 papers in Oncology and 12 papers in Cancer Research. Recurrent topics in Wenkai Ni's work include Ubiquitin and proteasome pathways (9 papers), Cancer-related Molecular Pathways (7 papers) and Cancer Mechanisms and Therapy (6 papers). Wenkai Ni is often cited by papers focused on Ubiquitin and proteasome pathways (9 papers), Cancer-related Molecular Pathways (7 papers) and Cancer Mechanisms and Therapy (6 papers). Wenkai Ni collaborates with scholars based in China and United States. Wenkai Ni's co-authors include Runzhou Ni, Mingbing Xiao, Cuihua Lu, Feng Jiang, Jinxia Liu, Lishuai Qu, Buyou Chen, Saiyan Bian, Jing Zhu and Lili Yu and has published in prestigious journals such as Cell Death and Differentiation, Cancer Letters and BioMed Research International.

In The Last Decade

Wenkai Ni

42 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenkai Ni China 19 835 380 180 174 106 42 1.1k
Tianqi Wu China 20 669 0.8× 556 1.5× 134 0.7× 176 1.0× 156 1.5× 38 1.1k
Amos M. Sakwe United States 20 727 0.9× 365 1.0× 100 0.6× 119 0.7× 91 0.9× 47 997
Xiaocheng Zhou China 16 623 0.7× 488 1.3× 133 0.7× 197 1.1× 108 1.0× 29 927
Anastasia Chillà Italy 23 667 0.8× 336 0.9× 234 1.3× 265 1.5× 69 0.7× 45 1.1k
Lei Xi China 13 504 0.6× 311 0.8× 116 0.6× 228 1.3× 81 0.8× 32 870
Jingqin Lan China 10 804 1.0× 387 1.0× 258 1.4× 170 1.0× 108 1.0× 13 1.0k
Ying Lin China 14 1.2k 1.4× 545 1.4× 391 2.2× 206 1.2× 103 1.0× 52 1.6k
Enrico Cappelli Italy 19 1.2k 1.5× 333 0.9× 146 0.8× 316 1.8× 65 0.6× 69 1.6k
Ling‐Min Kong China 14 588 0.7× 270 0.7× 136 0.8× 135 0.8× 62 0.6× 22 791

Countries citing papers authored by Wenkai Ni

Since Specialization
Citations

This map shows the geographic impact of Wenkai Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenkai Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenkai Ni more than expected).

Fields of papers citing papers by Wenkai Ni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenkai Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenkai Ni. The network helps show where Wenkai Ni may publish in the future.

Co-authorship network of co-authors of Wenkai Ni

This figure shows the co-authorship network connecting the top 25 collaborators of Wenkai Ni. A scholar is included among the top collaborators of Wenkai Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenkai Ni. Wenkai Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bian, Saiyan, Wenkai Ni, Xuying Zhao, et al.. (2024). Ubiquitin-specific protease 1 facilitates hepatocellular carcinoma progression by modulating mitochondrial fission and metabolic reprogramming via cyclin-dependent kinase 5 stabilization. Cell Death and Differentiation. 31(9). 1202–1218. 10 indexed citations
3.
Xu, Xuebing, Shengze Zhu, Jie Ji, et al.. (2023). Differences between migrasome, a ‘new organelle’, and exosome. Journal of Cellular and Molecular Medicine. 27(23). 3672–3680. 14 indexed citations
4.
Ni, Wenkai, Saiyan Bian, Mengqi Zhu, et al.. (2021). Identification and Validation of Ubiquitin-Specific Proteases as a Novel Prognostic Signature for Hepatocellular Carcinoma. Frontiers in Oncology. 11. 629327–629327. 15 indexed citations
5.
Lin, Shengli, Pingting Gao, Wenkai Ni, et al.. (2021). Controlled hypertension under hemostasis prevents post-gastric endoscopic submucosal dissection bleeding: a prospective randomized controlled trial. Surgical Endoscopy. 35(10). 5675–5685. 2 indexed citations
6.
Liu, Jinxia, Lishuai Qu, Chunhua Wan, et al.. (2020). A novel β2-AR/YB-1/β-catenin axis mediates chronic stress-associated metastasis in hepatocellular carcinoma. Oncogenesis. 9(9). 84–84. 26 indexed citations
7.
Zhang, Wei, Jingxin Zhang, Shiqing Zhang, et al.. (2020). Ubiquitin-specific protease 7 is a drug-able target that promotes hepatocellular carcinoma and chemoresistance. Cancer Cell International. 20(1). 28–28. 33 indexed citations
8.
Jin, Dandan, Jie Ji, Wei Jiang, et al.. (2020). Identification of prognostic risk factors for pancreatic cancer using bioinformatics analysis. PeerJ. 8. e9301–e9301. 13 indexed citations
9.
Chen, Xiaojun, Jie Ji, Rui Zhou, et al.. (2019). Progress of Exosomes in the Diagnosis and Treatment of Pancreatic Cancer. Genetic Testing and Molecular Biomarkers. 23(3). 215–222. 14 indexed citations
10.
Ni, Wenkai, Shiqing Zhang, Bo Jiang, et al.. (2019). Identification of cancer-related gene network in hepatocellular carcinoma by combined bioinformatic approach and experimental validation. Pathology - Research and Practice. 215(6). 152428–152428. 18 indexed citations
11.
Xiao, Mingbing, Dandan Jin, Wenkai Ni, et al.. (2018). β2-AR regulates the expression of AKR1B1 in human pancreatic cancer cells and promotes their proliferation via the ERK1/2 pathway. Molecular Biology Reports. 45(6). 1863–1871. 18 indexed citations
12.
Huang, Hua, Mingbing Xiao, Feng Jiang, et al.. (2017). Sex comb on midleg like-2 is a novel specific marker for the diagnosis of gastroenteropancreatic neuroendocrine tumors. Experimental and Therapeutic Medicine. 14(2). 1749–1755. 2 indexed citations
13.
Zhang, Xiubing, Pan Xu, Wenkai Ni, et al.. (2016). Downregulated DYRK2 expression is associated with poor prognosis and Oxaliplatin resistance in hepatocellular carcinoma. Pathology - Research and Practice. 212(3). 162–170. 31 indexed citations
14.
Liu, Jinxia, Wenkai Ni, Lishuai Qu, et al.. (2016). Decreased Expression of EHD2 Promotes Tumor Metastasis and Indicates Poor Prognosis in Hepatocellular Carcinoma. Digestive Diseases and Sciences. 61(9). 2554–2567. 14 indexed citations
15.
Zhang, Xiubing, Wenkai Ni, Weidong Shi, et al.. (2015). Expression and Clinical Role of Cdc5L as a Novel Cell Cycle Protein in Hepatocellular Carcinoma. Digestive Diseases and Sciences. 61(3). 795–805. 23 indexed citations
16.
Huang, Wei, Xiaopeng Cui, Yuyan Chen, et al.. (2015). High VRK1 expression contributes to cell proliferation and survival in hepatocellular carcinoma. Pathology - Research and Practice. 212(3). 171–178. 22 indexed citations
17.
Ni, Wenkai, Buyou Chen, Cuihua Lu, et al.. (2013). Overexpressed nuclear BAG‐1 in human hepatocellular carcinoma is associated with poor prognosis and resistance to doxorubicin. Journal of Cellular Biochemistry. 114(9). 2120–2130. 19 indexed citations
18.
Xiao, Mingbing, Runzhou Ni, Wenkai Ni, et al.. (2013). Serum GP73 is complementary to AFP and GGT-II for the diagnosis of hepatocellular carcinoma. Oncology Letters. 6(4). 1152–1158. 28 indexed citations
19.
Liu, Jinxia, Wenkai Ni, Mingbing Xiao, Feng Jiang, & Runzhou Ni. (2013). Decreased Expression and Prognostic Role of Mitogen-Activated Protein Kinase Phosphatase 4 in Hepatocellular Carcinoma. Journal of Gastrointestinal Surgery. 17(4). 756–765. 16 indexed citations
20.
Xiao, Mingbing, Feng Jiang, Wenkai Ni, et al.. (2011). High expression of S100A11 in pancreatic adenocarcinoma is an unfavorable prognostic marker. Medical Oncology. 29(3). 1886–1891. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tianqi Wu Breakdown of academic impact, for papers by Amos M. Sakwe Breakdown of academic impact, for papers by Xiaocheng Zhou Breakdown of academic impact, for papers by Anastasia Chillà Breakdown of academic impact, for papers by Lei Xi Breakdown of academic impact, for papers by Jingqin Lan Breakdown of academic impact, for papers by Ying Lin Breakdown of academic impact, for papers by Enrico Cappelli Breakdown of academic impact, for papers by Ling‐Min Kong
Rankless by CCL
2026